Effect of pleurodesis and bleomycin in malignant pleural effusions
Phase 3
- Conditions
- Pleural effusion.Pleural effusion, not elsewhere classified
- Registration Number
- IRCT20180813040779N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Cytologically confirmed malignant pleural fluid
No sensitivity to bleomycin
No history of previous chemotherapy with bleomycin
Exclusion Criteria
Previous history of pleurodesis
History of coagulation disorders
Patient dissatisfaction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of pleural effusion. Timepoint: Before the intervention and four weeks after the intervention. Method of measurement: Observation.
- Secondary Outcome Measures
Name Time Method